Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: milestone / Re: Wow: lambertslunatics
Wow
36
Jul 08, 2009 12:56PM
10
Jul 08, 2009 01:09PM
9
Jul 08, 2009 01:19PM
10
Jul 08, 2009 02:01PM
5
Jul 08, 2009 02:18PM
8
Jul 08, 2009 02:32PM
4
Jul 08, 2009 02:39PM
4
Jul 08, 2009 02:46PM
3
Jul 08, 2009 02:53PM

Jul 08, 2009 02:55PM
14
Jul 08, 2009 02:59PM
6
Jul 08, 2009 03:02PM
4
Jul 08, 2009 03:35PM
1
Jul 08, 2009 03:51PM
3
Jul 08, 2009 03:52PM
9
Jul 08, 2009 03:54PM
3
Jul 08, 2009 03:57PM
2
Jul 08, 2009 04:02PM
1
Jul 08, 2009 04:09PM
3
Jul 08, 2009 04:12PM
3
Jul 08, 2009 04:34PM
2
Jul 08, 2009 04:38PM
3
Jul 08, 2009 06:00PM

You like to ignore the part that CJ and Gloria, and even Dr. Falk are actually full time EMPLOYEES of other entities who pay or at least should be paying their salary. I have no quarrel with the BOD being compensated, in proportion to the company's financial strength and in proportion to the success of their direction. In CJ's case, he's collecting over $300K from BOD positions that he serves in as a representative of Swartz related entities, so this is quite different in character than what you are trying to imply in your posts on this topic. $300K is a substantial compensation package for someone who is attending intermittent Director meetings, and chairing committees (ironically committees that are approving this particular compensation package, lol)

Where in any PTSC filing does it indicate that any of these three are "managing directors" as you want to now make them? In fact, to the contrary, the proxy lists them as "non-employee directors" Secondly, a "managing director" in the context of your link has nothing to do with being a member of a board of directors of a public company, does it? What you are pointing to is actually the payscale for someone who, for example, is the "managing director" of a branch office of a company who may have offices in several states. The person who manages the office in L.A. for example, would be considered the "managing director" of that office.

Here's the pertinent description of how PTSC sees our BOD MEMBERS:

CARLTON M. JOHNSON, JR. Carlton Johnson has served as a Director of the Company since 2001, and is Chairman of the Executive Committee of the Board of Directors. Mr. Johnson is in-house legal counsel for Roswell Capital Partners, LLC, a position he has held since June 1996. Mr. Johnson has been admitted to the practice of law in Alabama since 1986, Florida since 1982 and Georgia since 1997. He has been a shareholder in the Pensacola, Florida AV- rated law firm of Smith, Sauer, DeMaria Johnson and was President-Elect of the 500 member Escambia-Santa Rosa Bar Association. He also served on the Florida Bar Young Lawyers Division Board of Governors. Mr. Johnson earned a degree in History/Political Science at Auburn University and Juris Doctor at Samford University - Cumberland School of Law. Mr. Johnson is also a director and member of the audit committee of Peregrine Pharmaceuticals, Inc., a publicly held company.

HELMUT FALK, JR. From 1992 until 2000, Dr. Falk served as the Director of Anesthesia of, and served on the medical executive committee for, The Johnson Memorial Hospital in Franklin, Indiana. Since 2000, Dr. Falk has worked at St. Francis Hospital in Mooresville, Indiana as a staff anesthesiologist and has been Chairman of its Pharmacy and Therapeutics Committee. Dr. Falk received his D.O. degree from the College of Osteopathic Medicine of the Pacific in 1987 and his B.S. in Biology from the University of California, Irvine in 1983. Dr. Falk is the son of the late Helmut Falk, who was the sole shareholder of nanoTronics and the Chairman and CEO of the Company until his death in July 1995. Dr. Falk is also an heir to the Helmut Falk Estate, which is the beneficial owner of the Company's shares held by the Helmut Falk Family Trust.
GLORIA H. FELCYN. Gloria Felcyn has served as a Director of the Company since October, 2002 and is the Chairman of the Audit Committee of the Board of Directors. Since 1982, Ms. Felcyn has been the principal in her own certified public accounting firm, during which time she represented Helmut Falk Sr. and nanoTronics, along with other major individual and corporate clients in Silicon Valley. Following Mr. Falk's death, Ms. Felcyn represented his estate and family trust as Executrix and Trustee of the Falk Estate and The Falk Trust. Prior to establishing her firm, Ms. Felcyn worked for the national accounting firm of Hurdman and Cranston from 1969 through 1970 and Price Waterhouse & Co. in San Francisco and New York City from 1970 through 1976, during which period, she represented major Fortune 500 companies. Subsequent to that, Ms. Felcyn worked in the field of International Tax Planning with a major Real Estate Syndication Company in Los Angeles until 1982 when she decided to start her own practice in Northern California. A major portion of Ms. Felcyn's current practice is “Forensic Accounting”, which involves valuation of business entities and investigation of assets. Ms. Felcyn has published tax articles for “The Tax Advisor” and co-authored a book published in 1982, “International Tax Planning”. Ms. Felcyn has a degree in Business Economics from Trinity University and is a member of the American Institute of CPA's.

Share
New Message
Please login to post a reply